Generex Announces Upgrade to OTCQB® Venture Market

Nov 30, 2017, GNBT OTC Disclosure & News Service Generex Biotechnology Corporation (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) (www.generex.com) today announced that trading in its common stock will be upgraded to the OTCQB® Venture Market on November 30, 2017 after a successful application to up-list from the OTC Pink Market. OTCQB® membership provides enhanced investor benefits, including more stringent reporting standards, increased analyst coverage and access to news services, as well as more comprehensive compliance requirements. Generex President & Chief Executive Officer, Joe Moscato, commented:
http://bit.ly/2BnOk15